Cargando…
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
BACKGROUND: DNA methylation is one of the most promising biomarkers in predicting the prognosis of colorectal cancer (CRC). We aimed to develop a DNA methylation biomarker that could evaluate the prognosis of CRC. METHODS: A promising DNA methylation biomarker was developed by hypermethylated genes...
Autores principales: | Li, Xuan, Cai, Du, Huang, Yaoyi, Xie, Yumo, Shen, Dingcheng, Yuan, Ze, Liu, Xiaoxia, Huang, Meijin, Luo, Yanxin, Yu, Huichuan, Wang, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077670/ https://www.ncbi.nlm.nih.gov/pubmed/37020199 http://dx.doi.org/10.1186/s12885-023-10765-x |
Ejemplares similares
-
Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies
por: Shen, Dingcheng, et al.
Publicado: (2022) -
Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells
por: Liu, Xiaoxia, et al.
Publicado: (2023) -
Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis
por: Li, Juan, et al.
Publicado: (2021) -
RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
por: Shen, Dingcheng, et al.
Publicado: (2023) -
Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes
por: Peng, Shaoyong, et al.
Publicado: (2023)